State Street Corp. Maintains Passive Stake in Rocket Pharma
Ticker: RCKTW · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**State Street still owns Rocket Pharma shares, no big changes.**
AI Summary
State Street Corporation, a major financial institution, filed an amended Schedule 13G on January 22, 2024, disclosing its ownership of Rocket Pharmaceuticals Inc. common stock as of December 31, 2023. This filing indicates that State Street continues to hold a significant, though passive, stake in Rocket Pharmaceuticals. For investors, this means a large institutional investor maintains confidence in Rocket Pharmaceuticals, which can be a positive signal, but it doesn't suggest any active management changes or new strategic moves from State Street.
Why It Matters
This filing shows a major institutional investor, State Street Corporation, continues to hold shares in Rocket Pharmaceuticals, signaling ongoing institutional confidence without any intent to influence company management.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate risks or significant changes for Rocket Pharmaceuticals.
Analyst Insight
An investor should note that a large institution like State Street Corporation continues to hold Rocket Pharmaceuticals stock, which can be a sign of stability, but this filing alone doesn't provide new reasons to buy or sell, as it's a passive disclosure.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Rocket Pharmaceuticals Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change or update to previously reported beneficial ownership of securities.
Who is the 'Reporting Person' in this filing?
The 'Reporting Person' is State Street Corporation, identified by its CIK 0000093751 and business address at 1 Congress Street, Boston, MA.
What is the 'Subject Company' of this filing?
The 'Subject Company' is Rocket Pharmaceuticals, Inc., identified by its CIK 0001281895 and business address at 350 Fifth Avenue, Suite 7530, New York, NY.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the common stock of Rocket Pharmaceuticals Inc. is 77313F106.
What was the 'Date of Event Which Requires Filing of This Statement'?
The 'Date of Event Which Requires Filing of This Statement' was December 31, 2023, as stated on the cover page of the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).